Heart and Vascular Institute, Cleveland Clinic, Cleveland, Ohio; Department of Cardiology, Spectrum Health Medical Group, Grand Rapids, Michigan.
Heart and Vascular Institute, Cleveland Clinic, Cleveland, Ohio.
J Card Fail. 2021 Jul;27(7):777-785. doi: 10.1016/j.cardfail.2021.02.012. Epub 2021 Feb 25.
The pulmonary artery pulsatility index (PAPi) has been studied to predict right ventricular failure (RVF) after left ventricular assist device (LVAD) implantation, but only as a single time point before LVAD implantation. Multiple clinical factors and therapies impact RV function in pre-LVAD patients. Thus, we hypothesized that serial PAPi measurements during cardiac intensive care unit (CICU) optimization before LVAD implantation would provide incremental risk stratification for early RVF after LVAD implantation.
Consecutive patients who underwent sequential pulmonary artery catherization with cardiac intensive care optimization before durable LVAD implantation were included. Serial hemodynamics were reviewed retrospectively across the optimization period. The optimal PAPi was defined by the initial PAPi + the PAPi at optimized hemodynamics. RVF was defined as need for a right ventricular assist device or prolonged inotrope use (>14 days postoperatively). Patients with early RVF had significantly lower mean optimal PAPi (3.5 vs 7.5, P < .001) compared with those who did not develop RVF. After adjusting for established risk factors of early RVF after LVAD implantation, the optimal PAPi was independently and incrementally associated with early RVF after LVAD implantation (odds ratio 0.64, 95% confidence interval 0.532-0.765, P < .0001).
Optimal PAPi achieved during medical optimization before LVAD implantation provides independent and incremental risk stratification for early RVF, likely identifying dynamic RV reserve.
肺动脉搏动指数(PAPi)已被研究用于预测左心室辅助装置(LVAD)植入后的右心衰竭(RVF),但仅作为 LVAD 植入前的单一时间点进行研究。在接受 LVAD 治疗的患者中,许多临床因素和治疗方法都会影响 RV 功能。因此,我们假设在 LVAD 植入前的心脏重症监护病房(CICU)优化期间进行连续的 PAPi 测量,将为 LVAD 植入后早期 RVF 提供额外的风险分层。
连续纳入在接受永久性 LVAD 植入前接受连续肺动脉导管插入术和心脏重症监护优化的患者。回顾性地对优化期间的连续血液动力学进行了审查。最佳 PAPi 定义为初始 PAPi+优化血液动力学时的 PAPi。RVF 定义为需要右心室辅助装置或延长儿茶酚胺类药物使用(术后>14 天)。与未发生 RVF 的患者相比,早期 RVF 患者的平均最佳 PAPi 明显较低(3.5 对 7.5,P<.001)。在校正了 LVAD 植入后早期 RVF 的既定危险因素后,最佳 PAPi 与 LVAD 植入后早期 RVF 独立且呈递增相关(比值比 0.64,95%置信区间 0.532-0.765,P<.0001)。
在 LVAD 植入前的医疗优化期间达到的最佳 PAPi 为早期 RVF 提供了独立且递增的风险分层,可能可以识别 RV 储备的动态变化。